Sustainable Sleep Goes Global: AdorEarth Surpasses 50,000 Customers and Disrupts the Bedding Industry
With a growing international customer base spanning Australia, the United States, the United Kingdom, Canada, and New Zealand, AdorEarth is carving out a name for itself in the global bedding industry by offering sustainable, high-performance sleep products that don't compromise on luxury.
AdorEarth was founded on a simple principle: people deserve better sleep, and the planet deserves better materials. What began as a boutique e-commerce store quickly evolved into a global brand as demand surged for breathable, eco-friendly alternatives to conventional bedding.
The company offers a carefully curated line of bamboo-based products including sheet sets, quilt covers, mattress toppers, and blankets. Each item is made from OEKO-TEX certified bamboo fabric, which is naturally hypoallergenic, moisture-wicking, antibacterial, and incredibly soft.
'We started with a goal to make sustainable sleep accessible and enjoyable,' said the brand's founder. 'Reaching over 50,000 customers is a meaningful step forward, not just in business growth, but in validating that people are ready to move toward more conscious choices in their homes.'
According to global industry data, the bedding market is projected to exceed USD $147 billion by 2028, with a growing segment driven by organic and eco-friendly materials. AdorEarth is capitalizing on this shift by focusing exclusively on direct-to-consumer sales through its online platform adorearth.com, allowing the company to maintain product integrity and foster a more transparent relationship with its customers.
By avoiding traditional retail markups and minimizing environmental impact through ethical sourcing and plastic-free packaging, AdorEarth has created a value proposition that appeals to both environmentally minded and design-conscious buyers.
What makes bamboo such a compelling material for bedding? Unlike conventional cotton, bamboo requires significantly less water to grow, regenerates naturally without pesticides, and is fully biodegradable. From a performance perspective, bamboo textiles offer year-round comfort, staying cool in the summer and warm in the winter. They are also ideal for people with allergies, eczema, or sensitive skin.
AdorEarth's customers consistently report improvements in sleep quality, reduction in night sweats, and a noticeable difference in overall comfort. You can browse their full product line, including popular cooling toppers and silky-smooth bamboo sheets, on their website at adorearth.com.
To mark the 50,000-customer milestone, AdorEarth has introduced a limited-time 'Sleep Green Bundle' featuring a selection of their best-selling bamboo bedding essentials. The bundle is designed to help new customers experience the full range of benefits without the need to purchase items individually.
The company is also preparing for several new product launches, including bamboo weighted blankets for stress relief, organic children's bedding in playful, non-toxic prints, and a hotel and spa collection aimed at boutique accommodations looking to upgrade their guest experience.
AdorEarth's rise has been powered in part by strong customer retention and organic referrals. Thousands of verified five-star reviews on their site and social platforms highlight not just product quality, but the emotional connection customers feel toward the brand. Many describe it as a 'life upgrade' or 'the best investment they've made in their home.'
This level of loyalty has helped the company grow without the need for heavy advertising spend, a rare feat in today's competitive direct-to-consumer market.
AdorEarth is a global bedding brand that creates high-quality bamboo-based products designed to support better sleep and a healthier planet. With over 50,000 customers across five countries and a rapidly expanding global footprint, the company continues to lead the way in sustainable, luxury home goods. To learn more, visit adorearth.com
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
11 minutes ago
- CNBC
Gold gains as soft U.S. data pressures dollar, fuels rate-cut bets
Gold edged higher on Wednesday, supported by a weaker dollar after mild U.S. inflation data cemented bets for an interest rate cut in September, while investors focused on this week's U.S.-Russia talks over the war in Ukraine. Spot gold was up 0.2% at $3,351.46 per ounce, as of 0239 GMT. U.S. gold futures for December delivery gained 0.1% to $3,401.60. "The fall in the USD enabled a moderate bounce in the gold price, with the precious metal oscillating around the $3,350 level ahead of the Trump-Putin meeting on Friday," said Tim Waterer, chief market analyst at KCM Trade. "If the meeting in Alaska doesn't resolve anything and the war in Ukraine continues, gold could be making a push back towards $3,400 once again." The summit between U.S. President Donald Trump and Russian President Vladimir Putin "is a listening exercise for the president," the White House said on Tuesday, tempering expectations for a quick Russia-Ukraine ceasefire deal. Data released on Tuesday showed that the U.S. Consumer Price Index (CPI) rose 0.2% in July, following a 0.3% increase in June. On a year-over-year basis, the CPI climbed 2.7%. The dollar index extended declines, making greenback-denominated assets more affordable to holders of other currencies. Markets are pricing in about a 90% chance of a Federal Reserve rate cut in September, with at least one additional reduction expected by the end of the year. Non-yielding gold thrives in a low-interest-rate environment. Easing trade tensions in the market, the United States and China have extended a tariff truce for another 90 days, staving off triple-digit duties on each other's goods. Investors are now awaiting more U.S. economic data due later this week, including the U.S. Producer Price Index, weekly jobless claims, and retail sales. Elsewhere, spot silver rose 0.7% to $38.14 per ounce, platinum gained 0.4% to $1,341.80 and palladium climbed 0.3% to $1,132.89.
Hypebeast
30 minutes ago
- Hypebeast
Honda and Amalgam Reveal Limited-Edition RA272 Scale Model
Summary HondaRacing Corporation has teamed up withAmalgam Collectionto honor the 60th anniversary of its firstFormula 1victory with a limited-edition scale model of the iconic RA272 (chassis #103). The original car, driven by Richie Ginther, claimed Honda's debut win at the 1965 Mexico Grand Prix — marking the first F1 victory for a Japanese car, engine and team. Hand-built by Amalgam's master craftsmen, the model is available in two sizes: a 1:8 scale version limited to just 30 units ($28,995 USD) and a 1:18 scale version limited to 300 units ($1,735 USD). Each piece features over 1,600 precisely engineered parts, including a fully replicated 1.5L V12 engine and comes with a display case, a numbered certificate of authenticity and a commemorative booklet signed by Honda Racing Corporation President Koji Watanabe. The models will debut at The Quail, A Motorsports Gathering on August 15 duringMonterey Car Weekbefore online sales begin. Built from digital scans of the original RA272 in the Honda Collection Hall in Motegi, Japan, the model captures every authentic detail, down to its painted livery and meticulously replicated engine components. Honda says the RA272 scale model is not just a collectible but 'an invitation to own a piece of our motorsport history.'
Business Upturn
5 hours ago
- Business Upturn
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029
By GlobeNewswire Published on August 13, 2025, 05:30 IST Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) — North America Leads Today, Asia Pacific to Record Fastest Growth The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period. This growth is propelled by surging R&D investments in drug discovery, strategic government funding, and the increasing adoption of automation in life sciences research. Download PDF Brochure: What Is Driving the Market Now? HTS adoption is accelerating due to innovations in automation, miniaturization, and high-content screening, which significantly reduce discovery timelines and enhance precision in identifying therapeutic candidates. Grants such as the USD 7.8 million awarded to the University of Pittsburgh for advanced drug discovery systems underscore growing institutional and government commitment to high-impact research. Why Does This Matter for Global Pharma and Biotech Leaders? The market represents a critical enabler for competitive advantage in lead discovery, target validation, compound profiling, and hit identification—processes essential for pipeline acceleration. While high instrument costs remain a barrier, particularly for automated liquid handling and high-resolution imaging systems, emerging markets such as China and India offer lucrative opportunities with strong government support and an expanding pharmaceutical manufacturing base. Who Are the Key Stakeholders? The HTS ecosystem spans pharmaceutical giants, biotechnology innovators, academic institutions, and technology providers, all collaborating to enhance assay development and manage the rising complexity of biological data. The consumables segment—driven by recurring purchases of reagents and kits—dominates the market, ensuring steady demand as HTS workflows expand globally. Request Sample Pages: Where Is Growth Coming From? North America currently leads, fueled by advanced HTS infrastructure, robust funding for life science research, and a thriving biotech sector. Asia Pacific is projected to be the fastest-growing region, supported by a diverse patient base, strong pharmaceutical capabilities, and favorable regulatory environments. How Are Market Leaders Responding? Thermo Fisher Scientific Inc. maintains global leadership through an extensive portfolio of automated systems, screening instruments, and consumables, underpinned by 3% annual R&D investment and strategic alliances. Agilent Technologies, Inc. offers highly customizable workflows via BioTek detection instruments and Gen6 software, strengthened by acquisitions such as e-MSion (US) to enhance mass spectrometry capabilities. Merck KGaA delivers a diverse portfolio of reagents, instruments, software, and services, leveraging global reach and deep customer relationships across pharma, academia, and government sectors. Market Outlook As automation, AI-driven data analysis, and advanced assay development converge, HTS will remain at the forefront of pharmaceutical innovation. Decision-makers who strategically invest in HTS capabilities today will be best positioned to accelerate therapeutic pipelines, capture market share, and deliver faster, more targeted treatments to market. For more information, Inquire Now Discover Connected Healthcare Market Opportunities: Drug Screening Market Carrier Screening Market Cell based Assays Market Label Free Detection Market Life Science Instrumentation Market Get access to the latest updates on High-Throughput Screening Companies and High-Throughput Screening Market Size Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
